Literature DB >> 15753306

Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion.

Santiago Zelenay1, Thiago Lopes-Carvalho, Iris Caramalho, Maria Francisca Moraes-Fontes, Manuel Rebelo, Jocelyne Demengeot.   

Abstract

Expression of the IL-2 receptor alpha chain (CD25) by peripheral CD4 T cells follows cellular activation. However, CD25 expression by CD4 cells is widely used as a marker to identify regulatory T cells (T(R)), although cells with regulatory properties are also found in the CD4+CD25- subset. By using in vivo functional assays and Foxp3 expression as a faithful marker of T(R) differentiation, we have evaluated the requirements for CD25 expression by peripheral T(R). We first show that in vivo depletion of CD25+ cells prevents the development of spontaneous encephalomyelitis in recombination-activating gene (RAG)-deficient anti-myelin basic protein T cell antigen receptor (TCR) transgenic mice, and allows disease induction in otherwise healthy RAG-competent transgenic mice. Similar treatment in normal thymectomized animals is followed by the fast recovery of a normal number of CD25+ T(R). Consistently, Foxp3-expressing T(R) encompassed in the CD25- cell population convert to CD25+ after homeostatic expansion and are selectable by IL-2 in vitro. Surface expression of CD25 on T(R) is controlled by the activity of conventional CD4 cells and is fully labile because it can be lost and regained without affecting the functional potential of the cells. These findings reveal that Foxp3-expressing CD25- cells constitute a peripheral reservoir of differentiated T(R), recruited to the CD25+ pool upon homeostatic expansion and/or activation. This analysis, together with the notion that physiological commitment of T(R) takes place exclusively in the thymus should help for the interpretation of experiments assessing peripheral T(R) differentiation from naive CD4 T cells, defined as CD25-.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15753306      PMCID: PMC554795          DOI: 10.1073/pnas.0408679102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide.

Authors:  M S Jordan; A Boesteanu; A J Reed; A L Petrone; A E Holenbeck; M A Lerman; A Naji; A J Caton
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

2.  Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment.

Authors:  O Annacker; O Burlen-Defranoux; R Pimenta-Araujo; A Cumano; A Bandeira
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

3.  CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10.

Authors:  O Annacker; R Pimenta-Araujo; O Burlen-Defranoux; T C Barbosa; A Cumano; A Bandeira
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

Review 4.  On the ontogeny and physiology of regulatory T cells.

Authors:  O Annacker; R Pimenta-Araujo; O Burlen-Defranoux; A Bandeira
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

5.  Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo.

Authors:  Marc A Gavin; Sally R Clarke; Ella Negrou; Alena Gallegos; Alexander Rudensky
Journal:  Nat Immunol       Date:  2001-12-10       Impact factor: 25.606

6.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

7.  Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.

Authors:  J Shimizu; S Yamazaki; S Sakaguchi
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

8.  Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance.

Authors:  Jun Shimizu; Sayuri Yamazaki; Takeshi Takahashi; Yasumasa Ishida; Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

9.  Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells.

Authors:  S J Bensinger; A Bandeira; M S Jordan; A J Caton; T M Laufer
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

10.  Hyper immunoglobulin E response in mice with monoclonal populations of B and T lymphocytes.

Authors:  M A Curotto de Lafaille; S Muriglan; M J Sunshine; Y Lei; N Kutchukhidze; G C Furtado; A K Wensky; D Olivares-Villagómez; J J Lafaille
Journal:  J Exp Med       Date:  2001-11-05       Impact factor: 14.307

View more
  83 in total

1.  An MHC-linked locus modulates thymic differentiation of CD4+CD25+Foxp3+ regulatory T lymphocytes.

Authors:  Julie Tellier; Joost P M van Meerwijk; Paola Romagnoli
Journal:  Int Immunol       Date:  2006-08-30       Impact factor: 4.823

2.  Depletion of foxp3(+) T cells abrogates tolerance of skin and heart allografts in murine mixed chimeras without the loss of mixed chimerism.

Authors:  K Shinoda; T Akiyoshi; C M Chase; E A Farkash; D K Ndishabandi; C M Raczek; D P Sebastian; P Della Pelle; P S Russell; J C Madsen; R B Colvin; A Alessandrini
Journal:  Am J Transplant       Date:  2014-08-25       Impact factor: 8.086

3.  Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells.

Authors:  Isabel Barao; Alan M Hanash; William Hallett; Lisbeth A Welniak; Kai Sun; Doug Redelman; Bruce R Blazar; Robert B Levy; William J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

4.  The regulatory T cells in anti-influenza antibody response post influenza vaccination.

Authors:  Shih-Min Wang; Ming-Hsun Tsai; Huan-Yao Lei; Jen-Ren Wang; Ching-Chuan Liu
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

5.  PI3Kδ inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemia.

Authors:  Bola S Hanna; Philipp M Roessner; Annika Scheffold; Billy M C Jebaraj; Yasmin Demerdash; Selcen Öztürk; Peter Lichter; Stephan Stilgenbauer; Martina Seiffert
Journal:  Leukemia       Date:  2018-12-20       Impact factor: 11.528

6.  Immunomodulatory effects of Trichinella spiralis-derived excretory-secretory antigens.

Authors:  Ivana Radovic; Alisa Gruden-Movsesijan; Natasa Ilic; Jelena Cvetkovic; Slavko Mojsilovic; Marija Devic; Ljiljana Sofronic-Milosavljevic
Journal:  Immunol Res       Date:  2015-03       Impact factor: 2.829

7.  Investigation of immune cell markers in feline oral squamous cell carcinoma.

Authors:  Ellen E Sparger; Brian G Murphy; Farina Mustaffa Kamal; Boaz Arzi; Diane Naydan; Chrisoula T Skouritakis; Darren P Cox; Katherine Skorupski
Journal:  Vet Immunol Immunopathol       Date:  2018-06-13       Impact factor: 2.046

8.  Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications.

Authors:  M Di Ianni; B Del Papa; D Cecchini; E Bonifacio; L Moretti; T Zei; R Iacucci Ostini; F Falzetti; L Fontana; G Tagliapietra; C Maldini; M F Martelli; A Tabilio
Journal:  Clin Exp Immunol       Date:  2009-03-09       Impact factor: 4.330

9.  The Nature of Increased Circulating CD4CD25Foxp3 T Cells in Patients with Systemic Lupus Erythematosus: A Novel Hypothesis.

Authors:  Bing Yan; Yi Liu
Journal:  Open Rheumatol J       Date:  2009-06-09

10.  Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy.

Authors:  Nicole Schmitz; Klaus Dietmeier; Monika Bauer; Melanie Maudrich; Stefan Utzinger; Simone Muntwiler; Philippe Saudan; Martin F Bachmann
Journal:  J Exp Med       Date:  2009-08-10       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.